Zura Bio Limited
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Zura Bio Limited's yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales grew in 0 of the last 3 years; profit grew in 1 of 3. Less steady than 86% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-8.2×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 51% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 1/3Sales grew in 0 of the last 3 years; profit grew in 1 of 3.
Less steady than 86% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
—Data incomplete
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (9)
Zura Bio Limited made a loss over the last year. Zura Bio Limited owes $0.08 for every $1 it owns. Zura Bio Limited made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossZura Bio Limited made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.72The share price is 1.72 times Zura Bio Limited's book value per share, lower than 64% of Healthcare companies in United States.
Market cap
$338 MThe total market value of all of Zura Bio Limited's shares at today's price (share price × number of shares), larger than 50% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$197 MWhat Zura Bio Limited would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$2.06Net worth divided by the number of shares. The share price of $3.53 is 1.7 times this, which is the P/B above.
Return on equity (ROE)
-51.0%Zura Bio Limited lost 51.0% of its shareholders' money over the last year, lower than 52% of Healthcare companies in United States.
Owes vs Owns
0.08×Zura Bio Limited owes $0.08 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Dividend yield
NoneZura Bio Limited does not currently pay a dividend.
Profit growth
LossZura Bio Limited made a loss in each of the last two years.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Zura Bio Limited: $338 M ÷ $197 M (30 Jun 2026) = 1.7.
What is Zura Bio Limited's return on equity?
Zura Bio Limited lost 51.0% of its shareholders' money over the last year, lower than 52% of Healthcare companies in United States.
How much does Zura Bio Limited owe compared with what it owns?
Zura Bio Limited owes $0.08 for every $1 it owns (low), lower than 91% of Healthcare companies in United States.
Does Zura Bio Limited pay a dividend?
No. Zura Bio Limited does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.